While the growing field of nanotechnology holds promise, particularly for darker skinned patients, it comes with its fair share of controversy.
Nanotechnology is the study of manipulating matter on a molecular scale by structuring ingredients into nanometer sized particles versus micrometer particles that are considerably larger.
The technology is currently being used in sunscreens, cosmetics, moisturizers, and anti-aging products because of properties that cannot be obtained using larger sized particles. In skin of color, nanotechnology has provided considerable benefit in the elegance of products, particularly sunscreens.
Chemical blockers in sunscreens, such as avobenzone, are greasy and difficult to blend. In addition, titanium dioxide leaves a white residue when applied to darker skin. When the ingredients are converted to nanoparticles, however, they are less greasy and leave the skin residue free while retaining their broad spectrum properties.
Because sunscreen use is much less prevalent in skin of color, particularly in black and Hispanic populations, skin cancer rates and photo-aging are on the rise in these populations. Although more educational and preventative health measures need to be undertaken, improvements in sunscreens may help drive use.
The safety of nanotechnology, however, has received considerable debate. Because the skin is the first line of defense, many dermatologists have concerns about the potential risk of nanotechnology.
Studies have shown that nanoparticles can enter skin with an altered integrity. Thus, products containing nanoparticles should never be used on damaged skin, burns, infants, and those with an inadequate skin barrier.
Considerable research on nanoparticles has shown that healthy, undamaged skin is an effective barrier for preventing the entry of nanoparticles into the deep layers of the dermis. And, the Food and Drug Administration’s Nanotechnology Task Force is currently investigating the safety of nanoparticles for skin care products because materials in the nano-scale dimension may have different chemical, physical, and biologic properties. The FDA has proposed guidelines for the use and development of nanotechnology to ensure patient safety and product efficacy.
Sunscreens are used to protect us from a known carcinogen: UV radiation. Nanoparticles have not been proven to be carcinogenic. In fact, sunscreens with nanoparticles have been shown to last longer, apply better to the skin, and provide better UVA and UVB protection than other products on the market.
We should encourage our skin of color patients that these products are safe and are more transparent than traditional products. This technology is providing more appealing products for us to offer our patients.
|
I am a: |
Interested in being notified of new Skin of Color news?
Click here to view our Skin of Color RSS Feed.
| May 19 - 22 Sao Paulo, | XXX RADLA 2012: Annual Meeting of Latin American Dermatologists |
| May 20 - 23 Brisbane, | Australasian College of Dermatologists: Annual Scientific Meeting |
| May 24 - 27 Chandler, AZ | American Society for MOHS Surgery (ASMS): Annual Dermatologic Surgery Clinical Symposium |
| May 25 - 28 Orlando, FL | Florida Society of Dermatology & Dermatologic Surgery (FSDDS): Annual Meeting |
| Jun 1 - 3 Hilton Head Island, SC | Georgia Society of Dermatologists (GSD): Annual Meeting |
| Jun 1 - 3 Dana Point, CA | Summit in Aesthetic Medicine 2012 |
| Jun 6 - 10 Verona, | European Academy of Dermatology and Venereology (EADV): Spring Symposium |
| Jun 7 - 8 New York, NY | New York University (NYU): Advances in Dermatology |
| Jun 12 - 16 Malmo, | European Society of Contact Dermatitis (ESCD): 11th Congress |
| Jun 15 Albany, NY | Albany Medical College: Annual Dermatology Teaching Day |
Seminars In Cutaneous Medicine And Surgery
March 2012 - Updates in Medical Dermatology
June 2012 - Frontiers in Dermatologic Surgery
September 2012 - eDermatology
December 2012 - Molecular Dermatology and Pathology
More Seminars »
This site complies with the HONcode standard for trustworthy health information: verify here.